Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients, a critical indicator of a patient's long-term survival. Outcomes data revealed that patients with even just one bone metastasis experience faster disease progression and worse overall survival.